AzTrials
AzTrials

Cerebral PalsyNCT04712708

Role of Rebound Therapy in the Rehabilitation of Children With Spastic Cerebral Palsy

A study testing Rebound Therapy and Physical Therapy Program in people with Cerebral Palsy, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cerebral palsy (CP) is a group of disorders of movement and posture, causing several body impairments. CP is caused by non-progressive disturbance that occurred in the fetal or immature brain. Read more about this study

Who is it for?
Ages 5 to 11 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Rebound Therapy and Physical Therapy Program
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteEgypt
Study dates
1 Nov 2020to 30 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Spastic cerebral palsy was determined according to the sample size calculation, was selected from the outpatient's clinic of the faculty of Physical Therapy Cairo University.
  • Level I according to the Gross Motor Function Classification System (GMFCS). Chronological age ranged from 5 to 11 years.
  • Height was above 1 meter.
  • Understand verbal command.
  • The degree of spasticity ranged from 1 to 1+ according to Modified Ashworth' Scale.
  • Rebound therapy using trampoline was used as the method of management in the study group in addition to the selected physical therapy program that was used in both groups, and the treatment sessions was provided in the out-patient clinic of the faculty of Physical Therapy Cairo University.

Who cannot join

  • Vertigo or dizziness.
  • Epilepsy.
  • Osteoporosis.

Trial locations and contacts

1 site in 1 country.

Faten Abdelaziem, PhD contact

+20 100 855 4818

faten.hassan@pt.cu.edu.eg

Egypt1 site, 1 recruiting
  • Faculty of Physical Therapy Cairo University

    Giza

    Faten Abdelaziem, PhD, +20 100 855 4818, faten.hassan@pt.cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Cerebral palsy (CP) is a group of disorders of movement and posture, causing several body impairments. CP is caused by non-progressive disturbance that occurred in the fetal or immature brain. CP symptoms include several motor disorders such as disturbances in sensation, coordination, cognition, communication and behavior in addition to disturbances in postural stability, balance and coordination.

Balance is the ability to maintain the center of body mass over the base of support. CP causes balance impairment which results in decrease in the child's mobility functions and causing activity limitation and participations restrictions.

Read more

Motor coordination is the registration of two or more things such as body movements , timing or sensory feedback into a harmonious relationship.

CP causes disturbances in motor coordination such as difficulties in the routine gross movements as running and jumping, and disturbances in common fine movements like buttoning, clothing or brushing hair Rebound therapy is an exercise therapy which uses mini trampolines, rebounders , Springfree Trampoline and Swiss balls, to provide opportunity to perform recreational movements for individuals with different body structural and functional impairments.

Conditions
Cerebral Palsy
Being tested
Rebound Therapy, Physical Therapy Program
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rebound TherapyDevice

    Rebound therapy is the therapeutic use of full sized trampoline or mini sized trampoline. It provides opportunities for exercise recreation and therapy; and it is distinct from gymnastic trampolining. It is used for facilitating movements, improving balance, enhancing coordination and promoting motor performances in children with different disorders includes learning disabilities, communication disorders and motor dysfunction (Rebound Therapy South Africa, 2020; The Chartered society of Physiotherapists, 2016).

  • Physical Therapy ProgramOther

    The Mat Exercises:

    Stretching exercises to all spastic muscle groups (Kalkman et al., 2018). Gentle exercises was applied for 40-60 seconds and repeated from 3-5 times/ movement as supported by (Fragala et al., 2003).

    Strengthening Exercises:

    Dynamic Rising Positioning

    The Gym Exercises:

Study groups in NCT04712708
Study groupRoleWhat they receive
Control GroupActive comparatorEighteen children with spastic CP will receive especially designed physical therapy program based on Neuro-Developmental treatment (NDT) approach with emphasis on exercise encourage independent standing, stretches exercises, strengthening exercises, approximation, enhancement and facilitation of gait patterning and ankle ROM exercises for one hour for 24 sessions
Receives: Other: Physical Therapy Program
Study GroupExperimentalighteen children with spastic CP will receive the same program that the control group received in addition to especially designed exercises using rebound therapy (Mini Trampoline) that include push up exercise, standing, squatting, single limb squatting, kneeling position, catching and throwing a ball over head in kneeling position, catching and throwing a ball over head in standing position, kicking the ball, broad jumping with assistance, jumping in place, for 1 hour three times per week for three successive months.
Receives: Device: Rebound Therapy; Other: Physical Therapy Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Balance

    Stationary Balance Using Biodex Balance System

    Measured: 12 Weeks

  2. Gross Motor Function

    Gross Motor Function using Gross Motor Function Measure (GMFM)

    Measured: 12 Weeks

  3. Gross Motor Coordination

    Gross Motor Coordination Using Gross Motor Coordination Quotient in BOT-2

    Measured: 12 Weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2021
  2. Study start1 Nov 2020
  3. Primary completion30 Jul 2021 (estimated)
  4. Study completion30 Jul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04712708
Sponsor's protocol ID
P.T. REC/012/002421
Status last verified
Dec 2020
First submitted
4 Jan 2021
Last updated
15 Jan 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Rebound Therapy and Physical Therapy Program in people with Cerebral Palsy, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Faten Abdelaziem, PhD (+20 100 855 4818, faten.hassan@pt.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Balance (time frame: 12 Weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in